These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20837356)

  • 1. Predictive factors for prolonged survival in recurrent endometrial carcinoma: Implications for follow-up protocol.
    Otsuka I; Uno M; Wakabayashi A; Kameda S; Udagawa H; Kubota T
    Gynecol Oncol; 2010 Dec; 119(3):506-10. PubMed ID: 20837356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 125 normalization with chemotherapy is independently predictive of survival in advanced endometrial cancer.
    Hoskins PJ; Le N; Correa R
    Gynecol Oncol; 2011 Jan; 120(1):52-5. PubMed ID: 20947152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K
    Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.
    Nofech-Mozes S; Ackerman I; Ghorab Z; Ismiil N; Thomas G; Covens A; Khalifa MA
    Am J Clin Pathol; 2008 Jun; 129(6):912-7. PubMed ID: 18480008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
    Rasool N; Fader AN; Seamon L; Neubauer NL; Shahin FA; Alexander HA; Moore K; Moxley K; Secord AA; Kunos C; Rose PG; O'Malley DM
    Gynecol Oncol; 2010 Jan; 116(1):10-4. PubMed ID: 19875158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study.
    Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
    Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence".
    Pollock J
    Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231
    [No Abstract]   [Full Text] [Related]  

  • 12. Misleading CA-125 levels and computed tomography images in an endometrial cancer patient.
    Tjalma WA
    J Obstet Gynaecol; 2004 Jun; 24(4):470-1. PubMed ID: 15203605
    [No Abstract]   [Full Text] [Related]  

  • 13. Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.
    Mulligan AM; Plotkin A; Rouzbahman M; Soslow RA; Gilks CB; Clarke BA
    Am J Surg Pathol; 2010 Aug; 34(8):1132-8. PubMed ID: 20588176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
    Santala M; Talvensaari-Mattila A
    Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary recurrences in patients with endometrial cancer.
    Dowdy SC; Mariani A; Bakkum JN; Cliby WA; Keeney GL; Podratz KC
    Gynecol Oncol; 2007 Nov; 107(2):242-7. PubMed ID: 17869330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of circulating tumor cells positive for thyroid transcription factor-1 (TTF-1) to predict recurrence and survival rates for endometrial carcinoma.
    Zhang Y; Qu X; Qu PP
    J BUON; 2016; 21(6):1491-1495. PubMed ID: 28039713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
    Rose PG; Sommers RM; Reale FR; Hunter RE; Fournier L; Nelson BE
    Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.